Search Within

Pamela R Drullinsky

Formats
  1. Meeting Abstract (58)
  2. Journal Article (32)
  3. Research Letter (1)
  4. Review (1)
Groups
  1. Breast Medicine Service (92)
  2. Department of Medicine (92)
  3. Solid Tumor Oncology Division (92)
  4. Survivorship Research (70)
  5. Epidemiology and Biostatistics (48)
  6. Population Sciences Research Program (47)

More Groups

People
  1. Andrew Zelenetz (35)
  2. Matthew Matasar (32)
  3. Anita Kumar (31)
  4. David Straus (31)
  5. Paul Hamlin (31)
  6. Alison Moskowitz (26)

More People

Years
  1. 2025 (1)
  2. 2024 (4)
  3. 2023 (1)
  4. 2022 (9)
  5. 2021 (10)
  6. 2020 (8)

More Years

Publications
  1. Journal of Clinical Oncology (20)
  2. Blood (17)
  3. Breast Cancer Research and Treatment (10)
  4. Cancer Research (9)
  5. Hematological Oncology (6)
  6. Clinical Cancer Research (4)

More Publications

Publishers
  1. American Society of Clinical Oncology (20)
  2. American Society of Hematology (17)
  3. American Association for Cancer Research (13)
  4. Springer (10)
  5. Elsevier Inc. (8)
  6. Wiley Blackwell (6)

More Publishers

Results (92)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • The safety of dose-dense doxorubicin and cyclophosphamide followed by paclitaxel with trastuzumab in HER-2/neu overexpressed/amplified breast cancer
    Journal Article

    Dang, C.; Fornier, M.; Sugarman, S.; Troso-Sandoval, T.; Lake, D.; D'Andrea, G.; Seidman, A.; Sklarin, N.; Dickler, M.; Currie, V.; more...
    Journal of Clinical Oncology (2008)

    Fulltext@MSK | Save
  • A pilot study of growth factor (GF) omission during paclitaxel (T) for women with early breast carcinoma (BC)
    Meeting Abstract

    Sugarman, S. M.; Wasserheit, C.; Hodgman, E.; Coglianese, M. E.; D'alessandro, A.; Fornier, M.; Troso-Sandoval, T.; D'Andrea, G.; Drullinsky, P.; Lake, D.; more...
    Breast Cancer Research and Treatment (2006)

    Fulltext@MSK | Save
  • Mature cardiac safety results of dose-dense (DD) doxorubicin and cyclophosphamide (AC) followed by paclitaxel (T) with trastuzumab (H) in HER2/neu overexpressed/amplified breast cancer (BCA)
    Meeting Abstract

    Dang, C.; Smith, K.; Fornier, M.; Sugarman, S.; Troso, T.; Lake, D.; D'Andrea, G.; Seidman, A.; Sklarin, N.; George, R.; more...
    Breast Cancer Research and Treatment (2006)

    Fulltext@MSK | Save
  • Prolonged dose-dense (DD) epirubicin and cyclophosphamide (EC) followed by paclitaxel (T) in breast cancer (BCA) is feasible
    Meeting Abstract

    Dang, C.; Smith, K.; Lake, D.; Fornier, M.; D'Andrea, G.; Seidman, A.; Sklarin, N.; Troso-Sandoval, T.; Sugarman, S.; Gilewski, T.; more...
    Breast Cancer Research and Treatment (2005)

    Fulltext@MSK | Save
  • Preliminary cardiac safety results of dose-dense (DD) doxorubicin and cyclophosphamide (AC) followed by paclitaxel (T) with trastuzumab (H) in HER2/neu overexpressed/amplified breast cancer (BCA)
    Meeting Abstract

    Dang, C.; Smith, K.; Lake, D.; Fornier, M.; D'Andrea, G.; Seidman, A.; Sklarin, N.; Troso-Sandoval, T.; Sugarman, S.; Gilewski, T.; more...
    Breast Cancer Research and Treatment (2005)

    Fulltext@MSK | Save
  • Telomerase activity and telomere length in acute and chronic leukemia, pre- and post-ex vivo culture
    Journal Article

    Engelhardt, M.; Mackenzie, K.; Drullinsky, P.; Silver, R. T.; Moore, M. A. S.
    Cancer Research (2000)

    Fulltext@MSK | Save
  • Telomerase activity and telomere length in pediatric patients with malignancies undergoing chemotherapy
    Journal Article

    Engelhardt, M.; Ozkaynak, M. F.; Drullinsky, P.; Sandoval, C.; Tugal, O.; Jayabose, S.; Moore, M. A. S.
    Leukemia (1998)

    Fulltext@MSK | Save
  • A phase I trial of a single high dose of idarubicin combined with high-dose cytarabine as induction therapy in relapsed or refractory adult patients with acute lymphoblastic leukemia
    Journal Article

    Weiss, M. A.; Drullinsky, P.; Maslak, P.; Scheinberg, D.; Golde, D. W.
    Leukemia (1998)

    Fulltext@MSK | Save
  • Telomerase activity and telomere length in CD34+ cells from acute and chronic leukemias, pre- and post-ex vivo expansion
    Meeting Abstract

    Engelhardt, M.; Silver, R. T.; Drullisky, P.; Moore, M. A. S.
    Experimental Hematology (1997)

    Fulltext@MSK | Save
  • Telomerase activity and telomere length in healthy donors and patients with leukemia, pre- and post-ex vivo expansion
    Meeting Abstract

    Engelhardt, M.; Silver, R. T.; Drullisky, P.; Moore, M. A. S.
    Blood (1997)

    Fulltext@MSK | Save